The presentation videos and slides for speakers’ lectures will be made available from 2 October 2024, provided that the speakers have granted us permission to do so.
Mpox Clinical Forum 2024
Related Enduring Materials
What's New
-
We are happy to announce that the 2nd edition of the Mpox Clinical Forum was held virtually on 12 September 2024.
-
To stay updated on the relevant developments, make sure you are signed up for our newsletter.
About this Program
For decades, Mpox has persistently affected communities in West and Central Africa, with reports of the disease dating back to the 1970s. Yet, despite its long-standing presence and impact, Mpox has struggled to receive the attention and resources it urgently needs, remaining a neglected tropical disease. The global outbreak that began in 2022 prompted the WHO to declare a Public Health Emergency of International Concern (PHEIC). Although this status was lifted in July 2023, the crisis has persisted.
As of 2024, Mpox has spread to 111 countries across all six WHO regions. On 13 August 2024, the Africa CDC declared Mpox a Public Health Emergency of Continental Security. Just one day later, the WHO reinstated the PHEIC designation for the MPXV clade I outbreak due to a sharp rise in cases.
The situation highlights a significant disparity in global response and resource allocation as many West and Central African countries are struggling with severe outbreaks, exacerbated by limited healthcare resources and considerable underreporting. The resurgence has also raised concerns about potential virus mutations, waning immunity, and the effectiveness of current treatment and vaccine strategies. Given these challenges, there is a pressing need for enhanced clinician education on Mpox, with a focus on updated surveillance and prophylactic strategies.
This program was designed to provide essential training for healthcare providers, drawing on insights from experienced clinicians and presenting the latest data on Mpox management and prevention.
General Information
-Infectious disease clinicians;
-Clinical virologists;
-Primary care physicians;
-Microbiologists; and
-Specialized nurses.
-Outline our current knowledge of the epidemiology of the Mpox outbreak;
-Categorize the various clinical symptoms for case recognition/definition; and
-Reflect on the therapeutical options for treatment and prevention.
Practical Information
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
The program of the 1st edition of the Mpox Clinical Forum 2022 can be found here
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and community representatives involved in Mpox.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Gabriele Gudaityte at gabriele.gudaityte@amededu.com or call +31 30 230 7140.